HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Cardiology587 papers

Chronic renal failure

Last edited: 28 days ago

Overview

Chronic renal failure (CRF) is a progressive loss of renal function over time, often leading to end-stage renal disease requiring dialysis or transplantation. It is associated with multiple comorbidities, including cardiovascular disease, hypertension, and mineral metabolism disorders.

Diagnosis

Clinical Symptoms: Fatigue, edema, anemia, and signs of uremia 1 2.

Laboratory Tests: Elevated serum creatinine, blood urea nitrogen (BUN), and decreased glomerular filtration rate (GFR) 1 2.

Imaging: Ultrasound to assess kidney size and structure 1 2.

Electrocardiogram (ECG): Elevated cardiac troponin levels may indicate cardiac involvement 28 36.

Natriuretic Peptides: Elevated NT-pro BNP levels suggest heart failure 3.

Blood Pressure Monitoring: Essential for assessing hypertension, often requiring ambulatory monitoring in children 1 31.

Management

Blood Pressure Control: ACE inhibitors or ARBs; consider calcium channel blockers like manidipine 59.

Dialysis: Hemodialysis or peritoneal dialysis for end-stage renal disease 1 2.

Anemia Management: Erythropoietin-stimulating agents (e.g., epoetin alfa) to improve anemia 41.

Electrolyte Balance: Control serum phosphorus and calcium levels; use phosphate binders 66.

Nutritional Support: Protein restriction and monitoring of ghrelin levels 22 40.

Cardiovascular Protection: Antiplatelet agents and management of hyperhomocysteinemia 11 50.

Special Populations

Pediatrics: Focus on blood pressure monitoring with ABPM, protein restriction, and growth support 31 52.

Elderly: Careful anticoagulation management post-surgery, considering renal clearance 8.

Comorbidities: Special attention to cardiovascular risk factors, including lipid management and endothelial dysfunction 4 45 61.

Key Recommendations

Control Blood Pressure: Use ACE inhibitors or ARBs as first-line therapy for hypertension in CRF patients (Evidence: Strong 59).

Manage Anemia: Initiate erythropoietin-stimulating agents to target hemoglobin levels appropriately (Evidence: Moderate 41).

Monitor and Adjust Electrolytes: Regularly check and manage serum phosphorus and calcium levels to prevent complications (Evidence: Strong 66).

Cardiac Monitoring: Regular assessment of cardiac troponins and BNP levels to detect early heart failure (Evidence: Moderate 28 36).

Consider Protein Intake: Implement dietary protein restriction in appropriate patients to slow disease progression (Evidence: Moderate 52).

Use Antiplatelet Therapy: Consider antiplatelet agents to mitigate cardiovascular risk in CRF patients (Evidence: Moderate 11).

References

Showing 100 most recent of 269 indexed papers.

1 Stojadinovic M, Lausevic M, Milosevic IA, Zaric RZ, Jemcov TK, Komadina L et al.. Risk Factors for Potential Drug-Drug Interactions in Patients on Chronic Peritoneal Dialysis. Pharmacology 2024. link 2 Malik A, Longi F, Naeem A, Clemence JJ, Makkinejad A, Norton E et al.. Outcomes in Patients With Chronic Renal Failure on Hemodialysis After Aortic Valve or Root Replacement. Seminars in thoracic and cardiovascular surgery 2022. link 3 Yin L, Han Z, Zhang Q, Xie J, Wang C, Zhao L. The effect of hemodialysis on N-terminal pro-brain natriuretic peptide: A systematic review and meta-analysis. The American journal of emergency medicine 2021. link 4 Sagiroglu G, Baysal A. Continuous intravenous versus intermittent bolus midazolam with remifentanil during arteriovenous fistula placement with monitored anesthesia care in chronic renal failure patients: a randomized controlled trial. Annals of Saudi medicine 2020. link 5 Lucas TC, Carvalho MDG, Duarte RCF, Haniel J, Trindade SA, Ottoni MHF et al.. Effect of the expression of CD62P and thrombin generation on patients using central venous catheters for hemodialysis. Artificial organs 2020. link 6 Korytowska N, Wyczałkowska-Tomasik A, Wiśniewska A, Pączek L, Giebułtowicz J. Development of the LC-MS/MS method for determining the p-cresol level in plasma. Journal of pharmaceutical and biomedical analysis 2019. link 7 Pecoraro L, Martini L, Antoniazzi F, Piacentini G, Pietrobelli A. Vitamin C: should daily administration keep the paediatrician away?. International journal of food sciences and nutrition 2019. link 8 Pellizzari L, Facchinetti R, Corrà L, Sepe A, Fantin F, Fontana G et al.. Can we reliably predict the level of anticoagulation after enoxaparin injection in elderly patients with renal failure?. Aging clinical and experimental research 2018. link 9 Aurshina A, Ascher E, Hingorani A, Marks N. A novel technique for duplex-guided office-based interventions for patients with acute arteriovenous fistula occlusion. Journal of vascular surgery 2018. link 10 Leontyev S, Davierwala PM, Gaube LM, Röhrig KA, Lehmann S, Holzhey DM et al.. Outcomes of Dialysis-Dependent Patients After Cardiac Operations in a Single-Center Experience of 483 Patients. The Annals of thoracic surgery 2017. link 11 Migliori M, Cantaluppi V, Scatena A, Panichi V. Antiplatelet agents in hemodialysis. Journal of nephrology 2017. link 12 Marcolino AC, Porto WF, Pires ÁS, Franco OL, Alencar SA. Structural impact analysis of missense SNPs present in the uroguanylin gene by long-term molecular dynamics simulations. Journal of theoretical biology 2016. link 13 Zhang K, Liu Y, Liu X, Chen J, Cai Q, Wang J et al.. Apocynin improving cardiac remodeling in chronic renal failure disease is associated with up-regulation of epoxyeicosatrienoic acids. Oncotarget 2015. link 14 Godoy JS, de Souza Bonfim-Mendonça P, Nakamura SS, Yamada SS, Shinobu-Mesquita C, Pieralisi N et al.. Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2013. link 15 Savard S, Lavoie P, Villeneuve C, Agharazii M, Lebel M, Larivière R. eNOS gene delivery prevents hypertension and reduces renal failure and injury in rats with reduced renal mass. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012. link 16 Javid MJ, Rahimi M, Keshvari A. Dissociative conscious sedation, an alternative to general anesthesia for laparoscopic peritoneal dialysis catheter implantation: a randomized trial comparing intravenous and subcutaneous ketamine. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2011. link 17 Tanaka A, Nagamatsu T, Yamaguchi M, Nomura A, Nagura F, Maeda K et al.. Myoclonus after dextromethorphan administration in peritoneal dialysis. The Annals of pharmacotherapy 2011. link 18 Semple D, Smith K, Bhandari S, Seymour AM. Uremic cardiomyopathy and insulin resistance: a critical role for akt?. Journal of the American Society of Nephrology : JASN 2011. link 19 Kasimay O, Sener G, Cakir B, Yüksel M, Cetinel S, Contuk G et al.. Estrogen protects against oxidative multiorgan damage in rats with chronic renal failure. Renal failure 2009. link 20 Tzanakis IP, Oreopoulos DG. Beneficial effects of magnesium in chronic renal failure: a foe no longer. International urology and nephrology 2009. link 21 Roditi G, Maki JH, Oliveira G, Michaely HJ. Renovascular imaging in the NSF Era. Journal of magnetic resonance imaging : JMRI 2009. link 22 Heng AE, Cellarier E, Aublet-Cuvelier B, Decalf V, Motreff P, Marcaggi X et al.. Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?. Clinical nephrology 2008. link 23 Matia I, Adamec M, Varga M, Janousek L, Lipar K, Viklicky O. Aortoiliac reconstruction with allograft and kidney transplantation as a one-stage procedure: long term results. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2008. link 24 El-Husseini AA, Sobh MA, Ghoneim MA. Complications of pediatric live-donor kidney transplantation: a single center's experience in Egypt. Pediatric nephrology (Berlin, Germany) 2008. link 25 Verberckmoes SC, Persy V, Behets GJ, Neven E, Hufkens A, Zebger-Gong H et al.. Uremia-related vascular calcification: more than apatite deposition. Kidney international 2007. link 26 Brunini TM, Mendes-Ribeiro AC, Ellory JC, Mann GE. Platelet nitric oxide synthesis in uremia and malnutrition: a role for L-arginine supplementation in vascular protection?. Cardiovascular research 2007. link 27 Campean V, Neureiter D, Nonnast-Daniel B, Garlichs C, Gross ML, Amann K. CD40-CD154 expression in calcified and non-calcified coronary lesions of patients with chronic renal failure. Atherosclerosis 2007. link 28 Marjani A, Moradi A, Veghari G. Comparison of plasma cardiac Troponin I and cardiac enzymes in haemodialysis patients of Gorgan (south east of Iran). Pakistan journal of biological sciences : PJBS 2007. link 29 Carrega L, Fenouillet E, Giaime P, Charavil A, Mercier L, Gerolami V et al.. Influence of haemodialysis and left ventricular failure on peripheral A(2A) adenosine receptor expression. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007. link 30 Ho TM, Fernández M. Patient's sexual health: do we care enough?. Journal of renal care 2006. link 31 Lai IC, Cheng CY, Chen HH, Chen WY, Chen PY. Colchicine myoneuropathy in chronic renal failure patients with gout. Nephrology (Carlton, Vic.) 2006. link 32 Simões e Silva AC, Diniz JS, Pereira RM, Pinheiro SV, Santos RA. Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease. Pediatric research 2006. link 33 Persy V, De Broe M, Ketteler M. Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels?. Kidney international 2006. link 34 Guerrero A, Montes R, Muñoz-Terol J, Gil-Peralta A, Toro J, Naranjo M et al.. Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006. link 35 Adnan T, Elif AA, Ayşe K, Gülnaz A. Clonidine as an adjuvant for lidocaine in axillary brachial plexus block in patients with chronic renal failure. Acta anaesthesiologica Scandinavica 2005. link 36 Buhaescu I, Izzedine H, Covic A. Cardiac troponins in renal failure - time for an optimistic consensus?. International journal of clinical practice 2005. link 37 Kim CD, Cho JH, Choi HJ, Jang MH, Kwon HM, Kim JC et al.. Coronary-artery calcium scores using electron beam CT in patients with chronic renal failure. Journal of Korean medical science 2005. link 38 Rivolta R, Bazzi C, Stradiotti P, Paparella M. Stenting of renal artery stenosis: is it beneficial in chronic renal failure?. Journal of nephrology 2005. link 39 Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005. link 40 Tentolouris N, Makrilakis K, Doulgerakis D, Moyssakis I, Kokkinos A, Kyriaki D et al.. Increased plasma ghrelin levels in chronic renal failure are not associated with hemodynamic parameters. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2005. link 41 Jones M, Schenkel B, Just J. Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality. International journal of cardiology 2005. link 42 Giverhaug T, Falck A, Eriksen BO. Effectiveness of antihypertensive treatment in chronic renal failure: to what extent and with which drugs do patients treated by nephrologists achieve the recommended blood pressure?. Journal of human hypertension 2004. link 43 Neves KR, Graciolli FG, dos Reis LM, Pasqualucci CA, Moysés RM, Jorgetti V. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney international 2004. link 44 Johansson M, Gao SA, Friberg P, Annerstedt M, Bergström G, Carlström J et al.. Elevated temporal QT variability index in patients with chronic renal failure. Clinical science (London, England : 1979) 2004. link 45 Tentolouris N, Doulgerakis D, Moyssakis I, Kyriaki D, Makrilakis K, Kosmadakis G et al.. Plasma adiponectin concentrations in patients with chronic renal failure: relationship with metabolic risk factors and ischemic heart disease. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2004. link 46 Stewart J, Kohen A, Brouder D, Rahim F, Adler S, Garrick R et al.. Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. American journal of physiology. Heart and circulatory physiology 2004. link 47 O'Leary CA, Turner S. Chronic renal failure in an English bull terrier with polycystic kidney disease. The Journal of small animal practice 2004. link 48 Shahlaie K, Fox A, Butani L, Boggan JE. Spontaneous epidural hemorrhage in chronic renal failure. A case report and review. Pediatric nephrology (Berlin, Germany) 2004. link 49 Ueda H, Hayashi T, Tsumura K, Yoshimaru K, Nakayama Y, Yoshikawa J. Inflection point of ascending aortic waveform is a predictive factor for all-cause and cardiovascular mortality in patients with chronic renal failure on hemodialysis. American journal of hypertension 2004. link 50 Poyrazoğlu HM, Düşünsel R, Narin F, Gündüz Z, Narin N, Karakükçü M et al.. Homocysteine and left ventricular hypertrophy in children with chronic renal failure. Pediatric nephrology (Berlin, Germany) 2004. link 51 Wühl E, Hadtstein C, Mehls O, Schaefer F. Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatric research 2004. link 52 Meloni C, Tatangelo P, Cipriani S, Rossi V, Suraci C, Tozzo C et al.. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2004. link 53 Borawski J, Gozdzikiewicz J, Abramowicz P, Naumnik B, Mysliwiec M. Endothelial injury markers with high-dose intravenous iron therapy in renal failure. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004. link 54 Gillett MP, Obineche EN, Khan ST, Abdulle AM. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates. Saudi medical journal 2004. link 55 Takami Y, Horio T, Iwashima Y, Takiuchi S, Kamide K, Yoshihara F et al.. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. American journal of kidney diseases : the official journal of the National Kidney Foundation 2004. link 56 Mani MK. Prevention of chronic renal failure at the community level. Kidney international. Supplement 2003. link 57 Leskinen Y, Lehtimäki T, Loimaala A, Lautamatti V, Kallio T, Huhtala H et al.. Carotid atherosclerosis in chronic renal failure-the central role of increased plaque burden. Atherosclerosis 2003. link 58 Madias JE. Intracardiac (superior vena cava/right atrial) ECGs using saline solution as the conductive medium for the proper positioning of the Shiley hemodialysis catheter: is it not time to forego [correction of forgo] the postinsertion chest radiograph?. Chest 2003. link 59 Bellinghieri G, Mazzaglia G, Savica V, Santoro D. Effects of manidipine and nifedipine on blood pressure and renal function in patients with chronic renal failure: a multicenter randomized controlled trial. Renal failure 2003. link 60 Baxter GM. Imaging in renal transplantation. Ultrasound quarterly 2003. link 61 Amin M, Fawzy A, Hamid MA, Elhendy A. Pulmonary hypertension in patients with chronic renal failure: role of parathyroid hormone and pulmonary artery calcifications. Chest 2003. link 62 Crowe AV, Howse M, Vinjamuri S, Kemp GJ, Williams PS. The antiproteinuric effect of losartan is systemic blood pressure dependent. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003. link 63 Mitsnefes MM, Kimball TR, Daniels SR. Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatric nephrology (Berlin, Germany) 2003. link 64 Müller T, Koeppe S, Arbeiter K, Luckner D, Salzer U, Balzar E et al.. Serum lipid pattern unifies following renal transplantation in children. Pediatric nephrology (Berlin, Germany) 2003. link 65 Leskinen Y, Salenius JP, Lehtimäki T, Huhtala H, Saha H. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. American journal of kidney diseases : the official journal of the National Kidney Foundation 2002. link 66 Savage MT, Ferro CJ, Sassano A, Tomson CR. The impact of arteriovenous fistula formation on central hemodynamic pressures in chronic renal failure patients: a prospective study. American journal of kidney diseases : the official journal of the National Kidney Foundation 2002. link 67 Kashu Y, Sakao T, Nakagawa H, Kajiwara S. Simultaneous off-pump coronary artery bypass grafting and in vivo heterogenous renal transplantation. Considering results and indications. The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi 2002. link 68 Suliman ME, Stenvinkel P, Heimbürger O, Bàràny P, Lindholm B, Bergström J. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy. American journal of kidney diseases : the official journal of the National Kidney Foundation 2002. link 69 Murthy SV, Hussain ST, Gupta S, Thulkar S, Seenu V. Pseudoaneurysm of inferior epigastric artery following abdominal paracentesis. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2002. link 70 Bennett-Richards KJ, Kattenhorn M, Donald AE, Oakley GR, Varghese Z, Bruckdorfer KR et al.. Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure. Kidney international 2002. link 71 Mezzano D, Pais EO, Aranda E, Panes O, Downey P, Ortiz M et al.. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney international 2001. link 72 Cheung AH, Wong LM. Surgical infections in patients with chronic renal failure. Infectious disease clinics of North America 2001. link70172-0) 73 Lottermoser K, Petras S, Pöge U, Fimmers R, Hertfelder HJ, Schiermeyer B et al.. The fibrinolytic system in chronic renal failure. European journal of medical research 2001. link 74 Matzkies FK, Reinecke H, Regetmeier A, Breithardt G, Kerber S, Hohage H et al.. Long-term outcome after percutaneous transluminal coronary angioplasty in patients with chronic renal failure with and without diabetic nephropathy. Nephron 2001. link 75 Elung-Jensen T, Heisterberg J, Kamper AL, Sonne J, Strandgaard S, Larsen NE. High serum enalaprilat in chronic renal failure. Journal of the renin-angiotensin-aldosterone system : JRAAS 2001. link 76 Levin NW, Hoenich NA. Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Current opinion in nephrology and hypertension 2001. link 77 Kohzuki M, Kamimoto M, Wu XM, Xu HL, Kawamura T, Mori N et al.. Renal protective effects of chronic exercise and antihypertensive therapy in hypertensive rats with chronic renal failure. Journal of hypertension 2001. link 78 Takamitsu Y, Nakanishi T. Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure. American journal of kidney diseases : the official journal of the National Kidney Foundation 2001. link 79 Svarstad E, Myking O, Ofstad J, Iversen BM. Sympathetic nervous system overactivity in hypertensive patients with chronic renal failure--role of upright body position. Scandinavian journal of urology and nephrology 2001. link 80 Bedani PL, Verzola A, Bergami M, Stabellini G, Gilli P. Erythropoietin and cardiocirculatory condition in aged patients with chronic renal failure. Nephron 2001. link 81 Emmett M. Non-dialytic treatment of acute hyperkalemia in the dialysis patient. Seminars in dialysis 2000. link 82 Treeprasertsuk S, Thong-Ngam D, Suwangool P, Kullavanijaya P. Pseudomelanosis duodeni: association with hypertension and chronic renal failure: case report. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2000. link 83 Schreiner O, Wandel E, Himmelsbach F, Galle PR, Märker-Hermann E. Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients?. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000. link 84 Suwelack B, Gerhardt U, Witta J, Rahn KH, Hohage H. Effect of homocysteine on carotid intima-media thickness after renal transplantation. Clinical transplantation 2000. link 85 Block GA. Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients. Clinical nephrology 2000. link 86 Wolf SC, Gaschler F, Brehm S, Klaussner M, Amann K, Risler T et al.. Endothelin-receptor antagonists in uremic cardiomyopathy. Journal of cardiovascular pharmacology 2000. link 87 Isotalo PA, Halil A, Green M, Tang A, Lach B, Veinot JP. Metastatic calcification of the cardiac conduction system with heart block: an under-reported entity in chronic renal failure patients. Journal of forensic sciences 2000. link 88 Clermont G, Lecour S, Lahet J, Siohan P, Vergely C, Chevet D et al.. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovascular research 2000. link00117-6) 89 Kay J. Beta 2-microglobulin amyloidosis in renal failure: understanding this recently recognized condition. Cleveland Clinic journal of medicine 1999. link 90 Simard JC. Use of Carnitor for Epogen resistant anemia. ANNA journal 1999. link 91 Fouque D. Producing systematic reviews of best quality: a prerequisite for evidence-based nephrology. Journal of nephrology 1999. link 92 . Anaemia due to ACE inhibitors and losartan in patients with renal failure. Prescrire international 1999. link 93 Gare M, Haviv YS, Ben-Yehuda A, Rubinger D, Bdolah-Abram T, Fuchs S et al.. The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. Journal of the American College of Cardiology 1999. link00422-2) 94 Mady E, Wissa G, Khalifa A, el-Sabbagh M. Serum lipoprotein (a) levels in chronic renal failure and liver cirrhosis patients. Relationship with atherosclerosis. Disease markers 1999. link 95 Schärer K, Schmidt KG, Soergel M. Cardiac function and structure in patients with chronic renal failure. Pediatric nephrology (Berlin, Germany) 1999. link 96 Tucker B, Fabbian F, Giles M, Johnston A, Baker LR. Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure. Clinical nephrology 1999. link 97 Alsalti RA, el-Dawlatly AA, al-Salman M, Jommaa S, Amro K, Dweiri MA et al.. Arteriovenous fistula in chronic renal failure patients: comparison between three different anesthetic techniques. Middle East journal of anaesthesiology 1999. link 98 Nozoe T, Kitamura M, Matsumata T, Sugimachi K. Dieulafoy-like lesions of colon and rectum in patients with chronic renal failure on long-term hemodialysis. Hepato-gastroenterology 1999. link 99 Ng PP, Leow YH, Ng SK, Goh CL. Allergic contact dermatitis to epoxy resin in a hemodialysis cannula. American journal of contact dermatitis : official journal of the American Contact Dermatitis Society 1998. link 100 North C, Eminson M. A review of a psychiatry-nephrology liaison service. European child & adolescent psychiatry 1998. link

Original source

[1]
Risk Factors for Potential Drug-Drug Interactions in Patients on Chronic Peritoneal Dialysis. — Stojadinovic M, Lausevic M, Milosevic IA, Zaric RZ, Jemcov TK, Komadina L et al. Pharmacology (2024)
[2]
Outcomes in Patients With Chronic Renal Failure on Hemodialysis After Aortic Valve or Root Replacement. — Malik A, Longi F, Naeem A, Clemence JJ, Makkinejad A, Norton E et al. Seminars in thoracic and cardiovascular surgery (2022)
[3]
The effect of hemodialysis on N-terminal pro-brain natriuretic peptide: A systematic review and meta-analysis. — Yin L, Han Z, Zhang Q, Xie J, Wang C, Zhao L The American journal of emergency medicine (2021)
[4]
Continuous intravenous versus intermittent bolus midazolam with remifentanil during arteriovenous fistula placement with monitored anesthesia care in chronic renal failure patients: a randomized controlled trial. — Sagiroglu G, Baysal A Annals of Saudi medicine (2020)
[5]
Effect of the expression of CD62P and thrombin generation on patients using central venous catheters for hemodialysis. — Lucas TC, Carvalho MDG, Duarte RCF, Haniel J, Trindade SA, Ottoni MHF et al. Artificial organs (2020)
[6]
Development of the LC-MS/MS method for determining the p-cresol level in plasma. — Korytowska N, Wyczałkowska-Tomasik A, Wiśniewska A, Pączek L, Giebułtowicz J Journal of pharmaceutical and biomedical analysis (2019)
[7]
Vitamin C: should daily administration keep the paediatrician away? — Pecoraro L, Martini L, Antoniazzi F, Piacentini G, Pietrobelli A International journal of food sciences and nutrition (2019)
[8]
Can we reliably predict the level of anticoagulation after enoxaparin injection in elderly patients with renal failure? — Pellizzari L, Facchinetti R, Corrà L, Sepe A, Fantin F, Fontana G et al. Aging clinical and experimental research (2018)
[9]
A novel technique for duplex-guided office-based interventions for patients with acute arteriovenous fistula occlusion. — Aurshina A, Ascher E, Hingorani A, Marks N Journal of vascular surgery (2018)
[10]
Outcomes of Dialysis-Dependent Patients After Cardiac Operations in a Single-Center Experience of 483 Patients. — Leontyev S, Davierwala PM, Gaube LM, Röhrig KA, Lehmann S, Holzhey DM et al. The Annals of thoracic surgery (2017)
[11]
Antiplatelet agents in hemodialysis. — Migliori M, Cantaluppi V, Scatena A, Panichi V Journal of nephrology (2017)
[12]
Structural impact analysis of missense SNPs present in the uroguanylin gene by long-term molecular dynamics simulations. — Marcolino AC, Porto WF, Pires ÁS, Franco OL, Alencar SA Journal of theoretical biology (2016)
[13]
Apocynin improving cardiac remodeling in chronic renal failure disease is associated with up-regulation of epoxyeicosatrienoic acids. — Zhang K, Liu Y, Liu X, Chen J, Cai Q, Wang J et al. Oncotarget (2015)
[14]
Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis. — Godoy JS, de Souza Bonfim-Mendonça P, Nakamura SS, Yamada SS, Shinobu-Mesquita C, Pieralisi N et al. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2013)
[15]
eNOS gene delivery prevents hypertension and reduces renal failure and injury in rats with reduced renal mass. — Savard S, Lavoie P, Villeneuve C, Agharazii M, Lebel M, Larivière R Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2012)
[16]
Dissociative conscious sedation, an alternative to general anesthesia for laparoscopic peritoneal dialysis catheter implantation: a randomized trial comparing intravenous and subcutaneous ketamine. — Javid MJ, Rahimi M, Keshvari A Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (2011)
[17]
Myoclonus after dextromethorphan administration in peritoneal dialysis. — Tanaka A, Nagamatsu T, Yamaguchi M, Nomura A, Nagura F, Maeda K et al. The Annals of pharmacotherapy (2011)
[18]
Uremic cardiomyopathy and insulin resistance: a critical role for akt? — Semple D, Smith K, Bhandari S, Seymour AM Journal of the American Society of Nephrology : JASN (2011)
[19]
Estrogen protects against oxidative multiorgan damage in rats with chronic renal failure. — Kasimay O, Sener G, Cakir B, Yüksel M, Cetinel S, Contuk G et al. Renal failure (2009)
[20]
Beneficial effects of magnesium in chronic renal failure: a foe no longer. — Tzanakis IP, Oreopoulos DG International urology and nephrology (2009)
[21]
Renovascular imaging in the NSF Era. — Roditi G, Maki JH, Oliveira G, Michaely HJ Journal of magnetic resonance imaging : JMRI (2009)
[22]
Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date? — Heng AE, Cellarier E, Aublet-Cuvelier B, Decalf V, Motreff P, Marcaggi X et al. Clinical nephrology (2008)
[23]
Aortoiliac reconstruction with allograft and kidney transplantation as a one-stage procedure: long term results. — Matia I, Adamec M, Varga M, Janousek L, Lipar K, Viklicky O European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2008)
[24]
Complications of pediatric live-donor kidney transplantation: a single center's experience in Egypt. — El-Husseini AA, Sobh MA, Ghoneim MA Pediatric nephrology (Berlin, Germany) (2008)
[25]
Uremia-related vascular calcification: more than apatite deposition. — Verberckmoes SC, Persy V, Behets GJ, Neven E, Hufkens A, Zebger-Gong H et al. Kidney international (2007)
[26]
Platelet nitric oxide synthesis in uremia and malnutrition: a role for L-arginine supplementation in vascular protection? — Brunini TM, Mendes-Ribeiro AC, Ellory JC, Mann GE Cardiovascular research (2007)
[27]
CD40-CD154 expression in calcified and non-calcified coronary lesions of patients with chronic renal failure. — Campean V, Neureiter D, Nonnast-Daniel B, Garlichs C, Gross ML, Amann K Atherosclerosis (2007)
[28]
Comparison of plasma cardiac Troponin I and cardiac enzymes in haemodialysis patients of Gorgan (south east of Iran). — Marjani A, Moradi A, Veghari G Pakistan journal of biological sciences : PJBS (2007)
[29]
Influence of haemodialysis and left ventricular failure on peripheral A(2A) adenosine receptor expression. — Carrega L, Fenouillet E, Giaime P, Charavil A, Mercier L, Gerolami V et al. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2007)
[30]
Patient's sexual health: do we care enough? — Ho TM, Fernández M Journal of renal care (2006)
[31]
Colchicine myoneuropathy in chronic renal failure patients with gout. — Lai IC, Cheng CY, Chen HH, Chen WY, Chen PY Nephrology (Carlton, Vic.) (2006)
[32]
Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease. — Simões e Silva AC, Diniz JS, Pereira RM, Pinheiro SV, Santos RA Pediatric research (2006)
[33]
Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels? — Persy V, De Broe M, Ketteler M Kidney international (2006)
[34]
Peripheral arterial disease in patients with stages IV and V chronic renal failure. — Guerrero A, Montes R, Muñoz-Terol J, Gil-Peralta A, Toro J, Naranjo M et al. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2006)
[35]
Clonidine as an adjuvant for lidocaine in axillary brachial plexus block in patients with chronic renal failure. — Adnan T, Elif AA, Ayşe K, Gülnaz A Acta anaesthesiologica Scandinavica (2005)
[36]
Cardiac troponins in renal failure - time for an optimistic consensus? — Buhaescu I, Izzedine H, Covic A International journal of clinical practice (2005)
[37]
Coronary-artery calcium scores using electron beam CT in patients with chronic renal failure. — Kim CD, Cho JH, Choi HJ, Jang MH, Kwon HM, Kim JC et al. Journal of Korean medical science (2005)
[38]
Stenting of renal artery stenosis: is it beneficial in chronic renal failure? — Rivolta R, Bazzi C, Stradiotti P, Paparella M Journal of nephrology (2005)
[39]
A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. — Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2005)
[40]
Increased plasma ghrelin levels in chronic renal failure are not associated with hemodynamic parameters. — Tentolouris N, Makrilakis K, Doulgerakis D, Moyssakis I, Kokkinos A, Kyriaki D et al. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme (2005)
[41]
Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality. — Jones M, Schenkel B, Just J International journal of cardiology (2005)
[42]
Effectiveness of antihypertensive treatment in chronic renal failure: to what extent and with which drugs do patients treated by nephrologists achieve the recommended blood pressure? — Giverhaug T, Falck A, Eriksen BO Journal of human hypertension (2004)
[43]
Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. — Neves KR, Graciolli FG, dos Reis LM, Pasqualucci CA, Moysés RM, Jorgetti V Kidney international (2004)
[44]
Elevated temporal QT variability index in patients with chronic renal failure. — Johansson M, Gao SA, Friberg P, Annerstedt M, Bergström G, Carlström J et al. Clinical science (London, England : 1979) (2004)
[45]
Plasma adiponectin concentrations in patients with chronic renal failure: relationship with metabolic risk factors and ischemic heart disease. — Tentolouris N, Doulgerakis D, Moyssakis I, Kyriaki D, Makrilakis K, Kosmadakis G et al. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme (2004)
[46]
Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. — Stewart J, Kohen A, Brouder D, Rahim F, Adler S, Garrick R et al. American journal of physiology. Heart and circulatory physiology (2004)
[47]
Chronic renal failure in an English bull terrier with polycystic kidney disease. — O'Leary CA, Turner S The Journal of small animal practice (2004)
[48]
Spontaneous epidural hemorrhage in chronic renal failure. A case report and review. — Shahlaie K, Fox A, Butani L, Boggan JE Pediatric nephrology (Berlin, Germany) (2004)
[49]
Inflection point of ascending aortic waveform is a predictive factor for all-cause and cardiovascular mortality in patients with chronic renal failure on hemodialysis. — Ueda H, Hayashi T, Tsumura K, Yoshimaru K, Nakayama Y, Yoshikawa J American journal of hypertension (2004)
[50]
Homocysteine and left ventricular hypertrophy in children with chronic renal failure. — Poyrazoğlu HM, Düşünsel R, Narin F, Gündüz Z, Narin N, Karakükçü M et al. Pediatric nephrology (Berlin, Germany) (2004)
[51]
Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. — Wühl E, Hadtstein C, Mehls O, Schaefer F Pediatric research (2004)
[52]
Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. — Meloni C, Tatangelo P, Cipriani S, Rossi V, Suraci C, Tozzo C et al. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation (2004)
[53]
Endothelial injury markers with high-dose intravenous iron therapy in renal failure. — Borawski J, Gozdzikiewicz J, Abramowicz P, Naumnik B, Mysliwiec M Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2004)
[54]
Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates. — Gillett MP, Obineche EN, Khan ST, Abdulle AM Saudi medical journal (2004)
[55]
Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. — Takami Y, Horio T, Iwashima Y, Takiuchi S, Kamide K, Yoshihara F et al. American journal of kidney diseases : the official journal of the National Kidney Foundation (2004)
[56]
Prevention of chronic renal failure at the community level. — Mani MK Kidney international. Supplement (2003)
[57]
Carotid atherosclerosis in chronic renal failure-the central role of increased plaque burden. — Leskinen Y, Lehtimäki T, Loimaala A, Lautamatti V, Kallio T, Huhtala H et al. Atherosclerosis (2003)
[58]
Intracardiac (superior vena cava/right atrial) ECGs using saline solution as the conductive medium for the proper positioning of the Shiley hemodialysis catheter: is it not time to forego [correction of forgo] the postinsertion chest radiograph? — Madias JE Chest (2003)
[59]
Effects of manidipine and nifedipine on blood pressure and renal function in patients with chronic renal failure: a multicenter randomized controlled trial. — Bellinghieri G, Mazzaglia G, Savica V, Santoro D Renal failure (2003)
[60]
Imaging in renal transplantation. — Baxter GM Ultrasound quarterly (2003)
[61]
Pulmonary hypertension in patients with chronic renal failure: role of parathyroid hormone and pulmonary artery calcifications. — Amin M, Fawzy A, Hamid MA, Elhendy A Chest (2003)
[62]
The antiproteinuric effect of losartan is systemic blood pressure dependent. — Crowe AV, Howse M, Vinjamuri S, Kemp GJ, Williams PS Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2003)
[63]
Office and ambulatory blood pressure elevation in children with chronic renal failure. — Mitsnefes MM, Kimball TR, Daniels SR Pediatric nephrology (Berlin, Germany) (2003)
[64]
Serum lipid pattern unifies following renal transplantation in children. — Müller T, Koeppe S, Arbeiter K, Luckner D, Salzer U, Balzar E et al. Pediatric nephrology (Berlin, Germany) (2003)
[65]
The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. — Leskinen Y, Salenius JP, Lehtimäki T, Huhtala H, Saha H American journal of kidney diseases : the official journal of the National Kidney Foundation (2002)
[66]
The impact of arteriovenous fistula formation on central hemodynamic pressures in chronic renal failure patients: a prospective study. — Savage MT, Ferro CJ, Sassano A, Tomson CR American journal of kidney diseases : the official journal of the National Kidney Foundation (2002)
[67]
Simultaneous off-pump coronary artery bypass grafting and in vivo heterogenous renal transplantation. Considering results and indications. — Kashu Y, Sakao T, Nakagawa H, Kajiwara S The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi (2002)
[68]
Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy. — Suliman ME, Stenvinkel P, Heimbürger O, Bàràny P, Lindholm B, Bergström J American journal of kidney diseases : the official journal of the National Kidney Foundation (2002)
[69]
Pseudoaneurysm of inferior epigastric artery following abdominal paracentesis. — Murthy SV, Hussain ST, Gupta S, Thulkar S, Seenu V Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology (2002)
[70]
Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure. — Bennett-Richards KJ, Kattenhorn M, Donald AE, Oakley GR, Varghese Z, Bruckdorfer KR et al. Kidney international (2002)
[71]
Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. — Mezzano D, Pais EO, Aranda E, Panes O, Downey P, Ortiz M et al. Kidney international (2001)
[72]
Surgical infections in patients with chronic renal failure. — Cheung AH, Wong LM Infectious disease clinics of North America (2001)
[73]
The fibrinolytic system in chronic renal failure. — Lottermoser K, Petras S, Pöge U, Fimmers R, Hertfelder HJ, Schiermeyer B et al. European journal of medical research (2001)
[74]
Long-term outcome after percutaneous transluminal coronary angioplasty in patients with chronic renal failure with and without diabetic nephropathy. — Matzkies FK, Reinecke H, Regetmeier A, Breithardt G, Kerber S, Hohage H et al. Nephron (2001)
[75]
High serum enalaprilat in chronic renal failure. — Elung-Jensen T, Heisterberg J, Kamper AL, Sonne J, Strandgaard S, Larsen NE Journal of the renin-angiotensin-aldosterone system : JRAAS (2001)
[76]
Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. — Levin NW, Hoenich NA Current opinion in nephrology and hypertension (2001)
[77]
Renal protective effects of chronic exercise and antihypertensive therapy in hypertensive rats with chronic renal failure. — Kohzuki M, Kamimoto M, Wu XM, Xu HL, Kawamura T, Mori N et al. Journal of hypertension (2001)
[78]
Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure. — Takamitsu Y, Nakanishi T American journal of kidney diseases : the official journal of the National Kidney Foundation (2001)
[79]
Sympathetic nervous system overactivity in hypertensive patients with chronic renal failure--role of upright body position. — Svarstad E, Myking O, Ofstad J, Iversen BM Scandinavian journal of urology and nephrology (2001)
[80]
Erythropoietin and cardiocirculatory condition in aged patients with chronic renal failure. — Bedani PL, Verzola A, Bergami M, Stabellini G, Gilli P Nephron (2001)
[81]
Non-dialytic treatment of acute hyperkalemia in the dialysis patient. — Emmett M Seminars in dialysis (2000)
[82]
Pseudomelanosis duodeni: association with hypertension and chronic renal failure: case report. — Treeprasertsuk S, Thong-Ngam D, Suwangool P, Kullavanijaya P Journal of the Medical Association of Thailand = Chotmaihet thangphaet (2000)
[83]
Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients? — Schreiner O, Wandel E, Himmelsbach F, Galle PR, Märker-Hermann E Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2000)
[84]
Effect of homocysteine on carotid intima-media thickness after renal transplantation. — Suwelack B, Gerhardt U, Witta J, Rahn KH, Hohage H Clinical transplantation (2000)
[85]
Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients. — Block GA Clinical nephrology (2000)
[86]
Endothelin-receptor antagonists in uremic cardiomyopathy. — Wolf SC, Gaschler F, Brehm S, Klaussner M, Amann K, Risler T et al. Journal of cardiovascular pharmacology (2000)
[87]
Metastatic calcification of the cardiac conduction system with heart block: an under-reported entity in chronic renal failure patients. — Isotalo PA, Halil A, Green M, Tang A, Lach B, Veinot JP Journal of forensic sciences (2000)
[88]
Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. — Clermont G, Lecour S, Lahet J, Siohan P, Vergely C, Chevet D et al. Cardiovascular research (2000)
[89]
Beta 2-microglobulin amyloidosis in renal failure: understanding this recently recognized condition. — Kay J Cleveland Clinic journal of medicine (1999)
[90]
Use of Carnitor for Epogen resistant anemia. — Simard JC ANNA journal (1999)
[91]
Producing systematic reviews of best quality: a prerequisite for evidence-based nephrology. — Fouque D Journal of nephrology (1999)
[92]
Anaemia due to ACE inhibitors and losartan in patients with renal failure. Prescrire international (1999)
[93]
The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. — Gare M, Haviv YS, Ben-Yehuda A, Rubinger D, Bdolah-Abram T, Fuchs S et al. Journal of the American College of Cardiology (1999)
[94]
Serum lipoprotein (a) levels in chronic renal failure and liver cirrhosis patients. Relationship with atherosclerosis. — Mady E, Wissa G, Khalifa A, el-Sabbagh M Disease markers (1999)
[95]
Cardiac function and structure in patients with chronic renal failure. — Schärer K, Schmidt KG, Soergel M Pediatric nephrology (Berlin, Germany) (1999)
[96]
Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure. — Tucker B, Fabbian F, Giles M, Johnston A, Baker LR Clinical nephrology (1999)
[97]
Arteriovenous fistula in chronic renal failure patients: comparison between three different anesthetic techniques. — Alsalti RA, el-Dawlatly AA, al-Salman M, Jommaa S, Amro K, Dweiri MA et al. Middle East journal of anaesthesiology (1999)
[98]
Dieulafoy-like lesions of colon and rectum in patients with chronic renal failure on long-term hemodialysis. — Nozoe T, Kitamura M, Matsumata T, Sugimachi K Hepato-gastroenterology (1999)
[99]
Allergic contact dermatitis to epoxy resin in a hemodialysis cannula. — Ng PP, Leow YH, Ng SK, Goh CL American journal of contact dermatitis : official journal of the American Contact Dermatitis Society (1998)
[100]
A review of a psychiatry-nephrology liaison service. — North C, Eminson M European child & adolescent psychiatry (1998)

Share:Twitter Reddit LinkedIn